Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Pancreatic Neoplasms × IFL protocol × Clear all

Phase

Status

Withdrawn 1 Suspended 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 1 Pancreatic Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1

Interventions

Gemcitabine 21 Taxes 8 pembrolizumab 5 Capecitabine 5 Albumin-Bound Paclitaxel 5 Specimen Handling 4 Secretin 4 Radiosurgery 4 Oxaliplatin 4 Ascorbic Acid 4 130-nm albumin-bound paclitaxel 4 Surgical Procedures, Operative 3 Magnetic Resonance Spectroscopy 3 Irinotecan 3 Fluorouracil 3 Cisplatin 3 Biopsy 3 Bevacizumab 3 palbociclib 2 methylnaltrexone 2 folfirinox 2 fludarabine 2 entinostat 2 durvalumab 2 aldesleukin 2 Trastuzumab 2 Radiotherapy 2 Radiation 2 Palliative Care 2 Paclitaxel 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04270929 2021-06-01

PANC-001

Roger Williams Medical Center

Phase 1 Withdrawn

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡